Rhofade Cream
Product Images NDC 51862-765

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rhofade (NDC 51862-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Rhofade 01)

FDA Label Image

Image (Rhofade 02)

FDA Label Image

Image (Rhofade 03)

FDA Label Image

Image (Rhofade 04)

FDA Label Image

Image (Rhofade 05)

FDA Label Image

Principal Display Panel (30 g Tube Carton)

Principal Display Panel (30 g Tube Carton)
This is information about a topical cream called Rhofade containing oxymetazoline. Each gram of the cream contains 10 mg of oxymetazoline hydrochloride, equivalent to 8.8 mg of oxymetazoline free base. The cream is for topical use only and should be kept out of reach of children. The product is distributed by Mayne Pharma in Raleigh, NC and is a patented product. Please refer to the NDC number for further identification.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.